Retraction Note: Enhanced antitumor efficacy in colon cancer using EGF functionalized PLGA nanoparticles loaded with 5-Fluorouracil and perfluorocarbon - Takeaways - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Retraction Notice: Improved Antitumor Activity in Colon Cancer Utilizing EGF-Modified PLGA Nanoparticles Loaded with 5-Fluorouracil and Perfluorocarbon

  • By

  • Pingping Wu

  • Qing Zhou

  • Huayun Zhu

  • Yan Zhuang

  • Jun Bao

  • August 22, 2026

Share

  • 1

    The article titled 'Improved Antitumor Activity in Colon Cancer Utilizing EGF-Modified PLGA Nanoparticles Loaded with 5-Fluorouracil and Perfluorocarbon' has been retracted.

  • 2

    The retraction was prompted by post-publication concerns regarding the integrity of the article's images.

  • 3

    Similarities were noted between the fourth and sixth panels in the second row of Fig. 5A.

  • 4

    The authors did not respond to the concerns raised by the Editors regarding the article.

  • 5

    Due to the lack of response, the Editors lost confidence in the article's data and conclusions.

Original Source(s)

Retraction Note: Enhanced antitumor efficacy in colon cancer using EGF functionalized PLGA nanoparticles loaded with 5-Fluorouracil and perfluorocarbon

  • by Pingping Wu, Qing Zhou, Huayun Zhu, Yan Zhuang, Jun Bao

  • August 22, 2026

Related Content

Preoperative and early postoperative albumin thresholds, rather than ΔAlb, predict severe complications after colorectal cancer surgery: a multifactorial model and nomogram

Correction: Lipid profile-based prognostic nomograms for obstructive colorectal cancer: multi-cohort development and validation

Correction: Plasticity and antigen presentation by group 3 innate lymphoid cells in colorectal cancer